Skip to main content
Watch Insiders
Market intelligence
KLRSSector not reported

Kalaris Therapeutics, Inc. insider activity

In the last 90 days, 5 corporate insiders purchased $5,899,845 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$5,899,845
Corporate buyers
5
Latest transaction
May 20, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 20, 2026Srinivas AkkarajuDirector / 10% OwnerOpen Market Purchase244,300$4.83$1,179,969
May 20, 2026Samsara BioCapital L.p.Corporate insiderOpen Market Purchase244,300$4.83$1,179,969
May 20, 2026Samsara BioCapital Gp LlcCorporate insiderOpen Market Purchase244,300$4.83$1,179,969
Subscribe to see more data